Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
26.15
+0.32 (1.24%)
At close: Jul 29, 2025, 4:00 PM
26.15
0.00 (0.00%)
After-hours: Jul 29, 2025, 7:00 PM EDT

Company Description

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.

In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services.

The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents.

Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG
Fresenius Medical Care AG logo
CountryGermany
Founded1996
IPO DateSep 19, 1996
IndustryMedical Care Facilities
SectorHealthcare
Employees111,513
CEOHelen Giza

Contact Details

Address:
Else-Kröner-Strasse 1
Bad Homburg, 61352
Germany
Phone49 6172 609 0
Websitefreseniusmedicalcare.com

Stock Details

Ticker SymbolFMS
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyEUR
CIK Code0001333141
CUSIP Number358029106
ISIN NumberUS3580291066
SIC Code8090

Key Executives

NamePosition
Craig Cordola FACHE, M.B.A., M.H.A.Chief Executive Officer of Care Delivery and Member of Management Board
Dr. Katarzyna Mazur-Hofsab Ph.D.Chief Executive Officer of Care Enablement and Member of Management Board
Helen GizaChair of Management Board and Chief Executive Officer
Martin FischerChief Financial Officer and Member of the Management Board
Dr. Franklin W. Maddux F.A.C.P., M.D.Global Chief Medical Officer and Member of Management Board
Jorg HaringMember of the Management Board, Global Head of Legal,Compliance and Human Resources and Labor Director
Roberto FusteExecutive Advisor for Regional Strategy
Dr. Dominik HegerExecutive Vice President and Head of Investor Relations, Strategic Development and Communications
Joachim WeithSenior Vice President of Corporate Communications and Governmental Affairs
Dr. Gail-Suzanne BrownSenior Vice President of Research and Development

Latest SEC Filings

DateTypeTitle
Jun 27, 202511-KAnnual report of employee stock purchase, savings and similar plans
Jun 17, 20256-KReport of foreign issuer
Jun 5, 20256-KReport of foreign issuer
May 27, 2025SDForm - SD
May 23, 20256-KReport of foreign issuer
May 14, 20256-KReport of foreign issuer
May 6, 20256-KReport of foreign issuer
May 6, 20256-KReport of foreign issuer
Apr 10, 20256-KReport of foreign issuer
Apr 8, 20256-KReport of foreign issuer